CRC Clinical Trial
Official title:
Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy
Motus Gl is developing a single-use device that attaches to a standard colonoscope, thereby
integrating colon cleansing, screening and treatment into one procedure.
The device creates turbulence within the colon using water jets. The colon's fecal fluids are
evacuated by the system.
63 eligible subjects who are allocated for a diagnostic screening colonoscopy were enrolled
in the study. The assignment of the level of the bowel preparation agent was according to the
physician decision. Following preparation, enrolled subjects were intubated and cleansed
using a standard colonoscope with the Motus GI CleanUp device attached to it. At the end of
the procedure, subjects were followed through discharge and at 48 hours post procedure for
occurrence of adverse events.
40 subjects were enrolled under protocol Rev 1.0 used Motus GI CleanUp System Rev 1.0 31
subjects were enrolled under protocol Rev 2 used Motus GI CleanUp System Rev 1.5, due to
improvement made to the study device including the following:
1. One head that irrigates and evacuates instead of two heads
2. Elimination of the grinding mechanism and the motor to reduce the pipes' diameters while
keeping the same flow rate.
3. System adjustment to the above changes including updated software version.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05002270 -
JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation
|
Phase 1/Phase 2 | |
Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04981119 -
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
|
||
Active, not recruiting |
NCT01308086 -
Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04585035 -
Study to Evaluate D-1553 in Subjects With Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03665285 -
A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03336658 -
Intratumoral Budding (ITB) in Preoperative Biopsies of Colon and Rectal Cancer
|
||
Recruiting |
NCT06445062 -
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03875313 -
Study of CB-839 (Telaglenastat) in Combination With Talazoparib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT05382377 -
NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors
|
Early Phase 1 | |
Active, not recruiting |
NCT05314309 -
Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening
|
||
Recruiting |
NCT06259552 -
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
|
Phase 1 | |
Completed |
NCT05976282 -
Addressing Colorectal Cancer in South Florida Firefighters
|
N/A | |
Recruiting |
NCT01593098 -
A Prospective Study Into the Risk of Colorectal Neoplasms in Individuals With a Family History of Advanced Adenomas (Sibling AN Study)
|
||
Recruiting |
NCT03597581 -
A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer
|
Phase 1 | |
Terminated |
NCT05368688 -
Microbiome in Colorectal Cancer Onset and Progression
|
||
Completed |
NCT03965845 -
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06455254 -
Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
|
Phase 2 | |
Not yet recruiting |
NCT03601598 -
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04868773 -
Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
|
Phase 1 |